These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482 [TBL] [Abstract][Full Text] [Related]
3. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy? Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147 [TBL] [Abstract][Full Text] [Related]
4. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643 [TBL] [Abstract][Full Text] [Related]
5. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection? Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer. Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477 [TBL] [Abstract][Full Text] [Related]
7. ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer. Jensen JD; Knoop A; Ewertz M; Laenkholm AV Breast Cancer Res Treat; 2012 Apr; 132(2):511-21. PubMed ID: 21667123 [TBL] [Abstract][Full Text] [Related]
8. The feasibility of sentinel lymph node biopsy for gastric cancer: the experience from Serbia. Stojanovic D; Milenkovic SM; Mitrovic N; Marinkovic D; Stevanovic D; Radovanovic D J BUON; 2013; 18(1):162-8. PubMed ID: 23613402 [TBL] [Abstract][Full Text] [Related]
9. Analysis of sentinel node involvement in gastric cancer. Morita D; Tsuda H; Ichikura T; Kimura M; Aida S; Kosuda S; Inazawa J; Mochizuki H; Matsubara O Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1046-52. PubMed ID: 17632042 [TBL] [Abstract][Full Text] [Related]
10. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance]. Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796 [TBL] [Abstract][Full Text] [Related]
11. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study. Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895 [TBL] [Abstract][Full Text] [Related]
12. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis. St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040 [TBL] [Abstract][Full Text] [Related]
13. Indications for pancreaticosplenectomy in advanced gastric cancer. Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954 [TBL] [Abstract][Full Text] [Related]
14. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer. Espín F; Bianchi A; Llorca S; Feliu J; Palomera E; García O; Remon J; Suñol X Eur J Surg Oncol; 2012 Jun; 38(6):497-502. PubMed ID: 22445061 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node mapping and skip metastases in patients with early gastric cancer. Lee SE; Lee JH; Ryu KW; Cho SJ; Lee JY; Kim CG; Choi IJ; Kook MC; Nam BH; Park SR; Lee JS; Kim YW Ann Surg Oncol; 2009 Mar; 16(3):603-8. PubMed ID: 19127361 [TBL] [Abstract][Full Text] [Related]
16. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer. Jo MJ; Park JY; Song JS; Kook MC; Ryu KW; Cho SJ; Lee JH; Nam BH; Hong EK; Choi IJ; Kim YW World J Gastroenterol; 2015 Jan; 21(2):667-74. PubMed ID: 25593497 [TBL] [Abstract][Full Text] [Related]
17. HER2 status of gastric carcinoma and corresponding lymph node metastasis. Pagni F; Zannella S; Ronchi S; Garanzini C; Leone BE Pathol Oncol Res; 2013 Jan; 19(1):103-9. PubMed ID: 22907801 [TBL] [Abstract][Full Text] [Related]
18. Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes. Kochi M; Fujii M; Masuda S; Kanamori N; Mihara Y; Funada T; Tamegai H; Watanabe M; Suda H; Takayama T Diagn Pathol; 2013 Nov; 8():191. PubMed ID: 24261710 [TBL] [Abstract][Full Text] [Related]
19. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up. Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420 [TBL] [Abstract][Full Text] [Related]
20. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma. König AM; Reeh M; Dancau AM; Rathjens M; Gros S; Uzunoglu FG; Bockhorn M; Simon R; Sauter G; Marx A; Izbicki JR Anticancer Res; 2013 Nov; 33(11):4975-82. PubMed ID: 24222138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]